We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Benign Hematology

Journal Scan / Research · August 31, 2021

No Increase in Myelodystplastic Syndrome With Vitamin K Antagonists



Additional Info

Vitamin K antagonists did not increase the risk of myelodysplastic syndrome in a large-scale cohort study
Blood 2021 Apr 19;[EPub Ahead of Print], A Neumann, MJ Jabagi, M Zureik

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading